BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9136084)

  • 1. Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine.
    Parrish AR; Ramos KS
    J Cell Biochem; 1997 May; 65(2):267-75. PubMed ID: 9136084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered protein secretion and extracellular matrix deposition is associated with the proliferative phenotype induced by allylamine in aortic smooth muscle cells.
    Ramos KS; Weber TJ; Liau G
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):57-63. PubMed ID: 8424772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells.
    Wilson E; Parrish AR; Bral CM; Williams ES; Ramos KS
    Atherosclerosis; 2002 Jun; 162(2):289-97. PubMed ID: 11996948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells.
    Williams ES; Wilson E; Ramos KS
    Oxid Med Cell Longev; 2012; 2012():496540. PubMed ID: 22315656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
    Li G; Oparil S; Kelpke SS; Chen YF; Thompson JA
    Circulation; 2002 Aug; 106(7):854-9. PubMed ID: 12176960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.
    Li G; Chen YF; Kelpke SS; Oparil S; Thompson JA
    Circulation; 2000 Jun; 101(25):2949-55. PubMed ID: 10869268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty.
    Wang X; Louden C; Ohlstein EH; Stadel JM; Gu JL; Yue TL
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1365-72. PubMed ID: 8911275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin.
    Yue TL; McKenna PJ; Ohlstein EH; Farach-Carson MC; Butler WT; Johanson K; McDevitt P; Feuerstein GZ; Stadel JM
    Exp Cell Res; 1994 Oct; 214(2):459-64. PubMed ID: 7925641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
    Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin deficiency in rat vascular smooth muscle cells is associated with an inability to adhere to collagen and increased apoptosis.
    Weintraub AS; Schnapp LM; Lin X; Taubman MB
    Lab Invest; 2000 Nov; 80(11):1603-15. PubMed ID: 11092521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK.
    Sodhi CP; Batlle D; Sahai A
    Kidney Int; 2000 Aug; 58(2):691-700. PubMed ID: 10916092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure atmospheric pressure promotes an expression of osteopontin in human aortic smooth muscle cells.
    Iizuka K; Murakami T; Kawaguchi H
    Biochem Biophys Res Commun; 2001 May; 283(2):493-8. PubMed ID: 11327728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allylamine enhances c-Ha-ras protooncogene expression in rat aortic smooth muscle cells.
    Bowes RC; Ramos KS
    Toxicol Lett; 1993 Mar; 66(3):263-72. PubMed ID: 8475506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.
    Gadeau AP; Campan M; Millet D; Candresse T; Desgranges C
    Arterioscler Thromb; 1993 Jan; 13(1):120-5. PubMed ID: 8422334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin expression in spontaneously developed neointima in fowl (Gallus gallus).
    Kuykindoll RJ; Nishimura H; Thomason DB; Nishimoto SK
    J Exp Biol; 2000 Jan; 203(Pt 2):273-82. PubMed ID: 10607537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in osteopontin mRNA expression during phenotypic transition of rabbit arterial smooth muscle cells.
    Yamamoto M; Aoyagi M; Azuma H; Yamamoto K
    Histochem Cell Biol; 1997 Apr; 107(4):279-87. PubMed ID: 9151110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture.
    Hultgårdh-Nilsson A; Lövdahl C; Blomgren K; Kallin B; Thyberg J
    Cardiovasc Res; 1997 May; 34(2):418-30. PubMed ID: 9205557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose.
    Sodhi CP; Phadke SA; Batlle D; Sahai A
    Diabetes; 2001 Jun; 50(6):1482-90. PubMed ID: 11375351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin regulates α-smooth muscle actin and calponin in vascular smooth muscle cells.
    Gao H; Steffen MC; Ramos KS
    Cell Biol Int; 2012 Feb; 36(2):155-61. PubMed ID: 22032345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells.
    Jones SA; Patterson JL; Chao JT; Ramos KS; Wilson E
    J Cell Biochem; 2004 Apr; 91(6):1248-59. PubMed ID: 15048878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.